Details
Stereochemistry | RACEMIC |
Molecular Formula | C11H15NO |
Molecular Weight | 177.2429 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(N(C)C)C(=O)C1=CC=CC=C1
InChI
InChIKey=KBHMHROOFHVLBA-UHFFFAOYSA-N
InChI=1S/C11H15NO/c1-9(12(2)3)11(13)10-7-5-4-6-8-10/h4-9H,1-3H3
Metamfepramone (dimethylcathinone, dimethylpropion, and dimepropion) was synthesized by various routes in the 1930s and 1940s and clinically evaluated as anorectic as well as a treatment of hypotension and symptoms
of the common cold. It was widely used for the treatment of the common cold or hypotonic conditions. Due to its stimulating properties and its rapid metabolism resulting in major degradation products such as methylpseudoephedrine and methcathinone, it has been considered relevant for doping controls by the World Anti-Doping Agency (WADA). Metamfepramone was marketed as an appetite suppressant, but was made illegal in 2006.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19661559
One capsule (accounting for a total of 10mg
of metamfepramone-HCl), was orally ingested
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C47795
Created by
admin on Fri Dec 15 15:54:16 GMT 2023 , Edited by admin on Fri Dec 15 15:54:16 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
234706
Created by
admin on Fri Dec 15 15:54:16 GMT 2023 , Edited by admin on Fri Dec 15 15:54:16 GMT 2023
|
PRIMARY | |||
|
C034349
Created by
admin on Fri Dec 15 15:54:16 GMT 2023 , Edited by admin on Fri Dec 15 15:54:16 GMT 2023
|
PRIMARY | |||
|
1587
Created by
admin on Fri Dec 15 15:54:16 GMT 2023 , Edited by admin on Fri Dec 15 15:54:16 GMT 2023
|
PRIMARY | |||
|
C83947
Created by
admin on Fri Dec 15 15:54:16 GMT 2023 , Edited by admin on Fri Dec 15 15:54:16 GMT 2023
|
PRIMARY | |||
|
SUB08808MIG
Created by
admin on Fri Dec 15 15:54:16 GMT 2023 , Edited by admin on Fri Dec 15 15:54:16 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105245
Created by
admin on Fri Dec 15 15:54:16 GMT 2023 , Edited by admin on Fri Dec 15 15:54:16 GMT 2023
|
PRIMARY | |||
|
15351-09-4
Created by
admin on Fri Dec 15 15:54:16 GMT 2023 , Edited by admin on Fri Dec 15 15:54:16 GMT 2023
|
PRIMARY | |||
|
METAMFEPRAMONE
Created by
admin on Fri Dec 15 15:54:16 GMT 2023 , Edited by admin on Fri Dec 15 15:54:16 GMT 2023
|
PRIMARY | |||
|
239-384-1
Created by
admin on Fri Dec 15 15:54:16 GMT 2023 , Edited by admin on Fri Dec 15 15:54:16 GMT 2023
|
PRIMARY | |||
|
DTXSID7057650
Created by
admin on Fri Dec 15 15:54:16 GMT 2023 , Edited by admin on Fri Dec 15 15:54:16 GMT 2023
|
PRIMARY | |||
|
71872
Created by
admin on Fri Dec 15 15:54:16 GMT 2023 , Edited by admin on Fri Dec 15 15:54:16 GMT 2023
|
PRIMARY | |||
|
100000081215
Created by
admin on Fri Dec 15 15:54:16 GMT 2023 , Edited by admin on Fri Dec 15 15:54:16 GMT 2023
|
PRIMARY | |||
|
04A0P12FH2
Created by
admin on Fri Dec 15 15:54:16 GMT 2023 , Edited by admin on Fri Dec 15 15:54:16 GMT 2023
|
PRIMARY | |||
|
3772
Created by
admin on Fri Dec 15 15:54:16 GMT 2023 , Edited by admin on Fri Dec 15 15:54:16 GMT 2023
|
PRIMARY | |||
|
m321
Created by
admin on Fri Dec 15 15:54:16 GMT 2023 , Edited by admin on Fri Dec 15 15:54:16 GMT 2023
|
PRIMARY | Merck Index |
ACTIVE MOIETY
METABOLITE (PARENT)
SALT/SOLVATE (PARENT)